Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. HIMS
HIMS logo

HIMS

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

HIMS News

Q4 Earnings Overview for Healthcare Tech Stocks

2d agoYahoo Finance

Trump Announces Israel-Lebanon Ceasefire, Stocks Surge

2d agoCNBC

Stocks Rise on Ceasefire Agreement Between Israel and Lebanon

2d agoNewsfilter

Israel-Lebanon Ceasefire Boosts Market Sentiment

2d agostocktwits

FDA Signals Openness to Broader Testosterone Therapy Use

2d agostocktwits

US Stocks Close Higher with Chipmakers Rallying

3d agoNASDAQ.COM

FDA Lifts Restrictions on 12 Peptides, Boosting Hims & Hers

3d agostocktwits

Hims & Hers Health Stock Rises 11.12% on FDA Review News

3d agoFool

US Stocks Dip Slightly as Chipmakers Weigh on Market

3d agoNASDAQ.COM

US Stocks Rise Slightly, Chipmakers Rebound

3d agoNASDAQ.COM

Hims & Hers Health Eyes Peptides as Growth Potential Post-GLP-1

3d agoNewsfilter

Health Care Stocks Decline as NYSE Index Falls 0.8%

3d agoYahoo Finance

Hims & Hers Explores New Opportunities in Peptides

3d agoCNBC

Hims & Hers Shares Surge on FDA's Regulatory Shift for Peptides

3d agoseekingalpha

S&P 500 Index Surpasses 7,000 Mark

3d agostocktwits

FDA Reviews Peptide Substances, HIMS Stock Surges

3d agostocktwits